Back
ESC Premium Access

Long-term effects of an intensive prevention program (IPP) after acute myocardial infarction - the IPP Follow-up and Prevention Boost Trial

Session: Risk Factors and Prevention ePosters
Topic: Secondary Prevention
Speaker: Professor H. Wienbergen (Bremen, DE)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Professor Harm Wienbergen

Hospital Links der Weser, Bremen (Germany)
2 presentations
2 followers

217 more presentations in this session

The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis

Speaker: Doctor Z. Pan (Guangzhou, CN)

Access
Abstract
Slides
Like
Thumbnail

Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS

Speaker: Miss C. van 't Klooster (Utrecht, NL)

Access
Abstract
Slides
Like
Thumbnail

Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project

Speaker: Assistant Professor C. Wu (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study

Speaker: Mr C. Topriceanu (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions

Speaker: Doctor P. Welsh (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Professor H. Wienbergen, Doctor Z. Pan, Miss C. van 't Klooster, Assistant Professor C. Wu, Mr C. Topriceanu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources